EVMN Posts $125M Private Placement, $19.3M Net Income, +94% YoY Revenue, EVO301 Phase 2a AD Data, EVO756 Phase 2b CSU/AD 2026 Reads
Evommune, Inc. · PHARMACEUTICAL PREPARATIONS · Now $23.23
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS